3Beigel J, Bray M. Current and future antiviral therapy of severe seasonal and avian influenza [ J ]. Antiviral Res, 2008,78 ( 1 ) : 91-102.
4Fouchier R A, Munster V, Wallensten A, et al. Characterization of a novel influenza A virus hemagglutinin subtype (H16) obtained from black-headed gulls[J] .J Virol,2005,79(5) :2814-2822.
5de la Barrera C A, Reyes-Teran G. Influenza:forecast for a pandemic [J] .Arch Med Res,2005,36(6):628-636.
6de Wit E, Kawaoka Y, de Jong M D, et al. Pathogenicity of highly pathogenic avian influenza virus in mammals [ J ]. Vaccine, 2008, 26 (Suppl 4) :54-58.
7Buffer D. Swine flu goes global [ J ]. Nature, 2009,458 ( 7242 ) : 1082- 1083.
8Cohen J, Ensefink M. Infectious diseases. As swine flu circles globe, scientists grapple with basic questions [ J ]. Science, 2009,324 ( 5927 ) : 572-573.
9Hayden F. Developing new antiviral agents for influenza treatment:what does the future hold? [J]. Clin Infect Dis,2009,48(Suppl 1) : S3- S13.
10Wong J P, Christopher M E, Salazar A M, et al. Nucleic acid-based antiviral drugs against seasonal and avian influenza viruses[J]. Vaccine, 2007,25(16) :3175-3178.
